Trials / Completed
CompletedNCT02337465
KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer
Integrated 3D X-ray and Ultrasound Guided Radiation Therapy of Soft Tissue Targets
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Case Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial studies if kilo-voltage cone beam computed tomography (KV-CBCT) and ultrasound imaging works in guiding radiation therapy in patients with prostate, liver, or pancreatic cancer. Computer systems, such as KV-CBCT and ultrasound imaging, allow doctors to create a 3-dimensional picture of the tumor may help in planning radiation therapy and may result in more tumor cells being killed.
Detailed description
PRIMARY OBJECTIVES: I. To investigate the feasibility of combining on-board cone beam computed tomography (CBCT) with ultrasound imaging to overcome the shortcomings of CBCT or ultrasound imaging alone for imaging guided radiotherapy delivery. OUTLINE: Patients undergo ultrasound imaging prior to and during radiation therapy. Patients also undergo kilo-voltage cone beam computed tomography prior to radiation therapy. Update (2021/02/04): Removed secondary outcome "Incidence of Adverse Events Related to the Ultrasound Probe". Per PI: Study initially intended to involve a non-FDA approved probe for use with liver patients but removed this section.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cone-Beam Computed Tomography | Undergo kilo-voltage cone beam computed tomography |
| RADIATION | 3-Dimensional Ultrasound-Guided Radiation Therapy | Undergo ultrasound-guided radiation therapy |
Timeline
- Start date
- 2015-09-22
- Primary completion
- 2019-12-14
- Completion
- 2019-12-14
- First posted
- 2015-01-13
- Last updated
- 2021-02-23
- Results posted
- 2021-02-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02337465. Inclusion in this directory is not an endorsement.